Ardelyx Inc (ARDX)
6.60
+0.21
(+3.27%)
USD |
NASDAQ |
May 01, 16:00
6.78
+0.18
(+2.73%)
After-Hours: 17:31
Ardelyx Total Long Term Debt (Quarterly): 49.82M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 49.82M |
September 30, 2023 | 27.23M |
June 30, 2023 | 27.05M |
March 31, 2023 | 26.88M |
December 31, 2022 | 26.71M |
September 30, 2022 | 26.54M |
June 30, 2022 | 26.37M |
March 31, 2022 | 26.14M |
December 31, 2021 | 32.26M |
September 30, 2021 | 51.48M |
June 30, 2021 | 51.24M |
March 31, 2021 | 51.02M |
December 31, 2020 | 50.79M |
September 30, 2020 | 50.68M |
June 30, 2020 | 50.45M |
March 31, 2020 | 50.23M |
December 31, 2019 | 50.01M |
September 30, 2019 | 49.80M |
June 30, 2019 | 49.60M |
March 31, 2019 | 49.40M |
December 31, 2018 | 49.21M |
September 30, 2018 | 49.02M |
Date | Value |
---|---|
June 30, 2018 | 48.84M |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
26.14M
Minimum
Mar 2022
51.48M
Maximum
Sep 2021
40.75M
Average
49.80M
Median
Sep 2019
Total Long Term Debt (Quarterly) Benchmarks
Nektar Therapeutics | 0.00 |
Omeros Corp | -- |
Vistagen Therapeutics Inc | 0.00 |
Karyopharm Therapeutics Inc | 170.92M |
Adverum Biotechnologies Inc | -- |